These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28962438)

  • 1. Fisetin targets phosphatidylinositol-3-kinase and induces apoptosis of human B lymphoma Raji cells.
    Lim JY; Lee JY; Byun BJ; Kim SH
    Toxicol Rep; 2015; 2():984-989. PubMed ID: 28962438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of mTOR Inhibitor Rapamycin on Burkitt's Lymphoma Cells].
    Zhou LH; Zhu XP; Xiao HF; Xin PL; Li CT
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1397-1405. PubMed ID: 29070114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fisetin's Promising Antitumor Effects: Uncovering Mechanisms and Targeting for Future Therapies.
    Qaed E; Al-Hamyari B; Al-Maamari A; Qaid A; Alademy H; Almoiliqy M; Munyemana JC; Al-Nusaif M; Alafifi J; Alyafeai E; Safi M; Geng Z; Tang Z; Ma X
    Glob Med Genet; 2023 Sep; 10(3):205-220. PubMed ID: 37565061
    [No Abstract]   [Full Text] [Related]  

  • 4. Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells.
    Pal HC; Baxter RD; Hunt KM; Agarwal J; Elmets CA; Athar M; Afaq F
    Oncotarget; 2015 Sep; 6(29):28296-311. PubMed ID: 26299806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant reduction of c-Myc expression and PI3K/AKT/mTOR signaling by quercetin induces a strong cytotoxic effect against Burkitt's lymphoma.
    Granato M; Rizzello C; Romeo MA; Yadav S; Santarelli R; D'Orazi G; Faggioni A; Cirone M
    Int J Biochem Cell Biol; 2016 Oct; 79():393-400. PubMed ID: 27620077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review on the chemotherapeutic potential of fisetin: In vitro evidences.
    Sundarraj K; Raghunath A; Perumal E
    Biomed Pharmacother; 2018 Jan; 97():928-940. PubMed ID: 29136771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive view on the fisetin impact on colorectal cancer in animal models: Focusing on cellular and molecular mechanisms.
    Zamanian MY; Taheri N; Ramadan MF; Mustafa YF; Alkhayyat S; Sergeevna KN; Alsaab HO; Hjazi A; Molavi Vasei F; Daneshvar S
    Animal Model Exp Med; 2024 Oct; 7(5):591-605. PubMed ID: 39136058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of new fisetin analogs as kinase inhibitors: Data on synthesis and anti-skin cancer activities evaluation.
    Roy T; Boateng ST; Banang-Mbeumi S; Singh PK; Basnet P; Chamcheu RN; Ladu F; Chauvin I; Spiegelman VS; Hill RA; Kousoulas KG; Nagalo BM; Walker AL; Fotie J; Murru S; Sechi M; Chamcheu JC
    Data Brief; 2021 Apr; 35():106858. PubMed ID: 33665254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Effects of Fisetin Against 6-OHDA-Induced Apoptosis by Activation of PI3K-Akt Signaling in Human Neuroblastoma SH-SY5Y Cells.
    Watanabe R; Kurose T; Morishige Y; Fujimori K
    Neurochem Res; 2018 Feb; 43(2):488-499. PubMed ID: 29204750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the PI3K/AKT-NF-κB pathway with curcumin enhanced radiation-induced apoptosis in human Burkitt's lymphoma.
    Qiao Q; Jiang Y; Li G
    J Pharmacol Sci; 2013; 121(4):247-56. PubMed ID: 23603894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dual PI3K/mTOR inhibitor NVP-BEZ235 inhibits proliferation and induces apoptosis of burkitt lymphoma cells.
    Li C; Xin P; Xiao H; Zheng Y; Huang Y; Zhu X
    Cancer Cell Int; 2015; 15():65. PubMed ID: 26130968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and ligand-based design of mTOR and PI3-kinase inhibitors leading to the clinical candidates VS-5584 (SB2343) and SB2602.
    Poulsen A; Nagaraj H; Lee A; Blanchard S; Soh CK; Chen D; Wang H; Hart S; Goh KC; Dymock B; Williams M
    J Chem Inf Model; 2014 Nov; 54(11):3238-50. PubMed ID: 25317974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fisetin induces apoptosis in breast cancer MDA-MB-453 cells through degradation of HER2/neu and via the PI3K/Akt pathway.
    Guo G; Zhang W; Dang M; Yan M; Chen Z
    J Biochem Mol Toxicol; 2019 Apr; 33(4):e22268. PubMed ID: 30431692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-21 and microRNA-155 promote the progression of Burkitt's lymphoma by the PI3K/AKT signaling pathway.
    Han B; Wang S; Zhao H
    Int J Clin Exp Pathol; 2020; 13(1):89-98. PubMed ID: 32055277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fisetin Suppresses Lipid Accumulation in Mouse Adipocytic 3T3-L1 Cells by Repressing GLUT4-Mediated Glucose Uptake through Inhibition of mTOR-C/EBPα Signaling.
    Watanabe M; Hisatake M; Fujimori K
    J Agric Food Chem; 2015 May; 63(20):4979-87. PubMed ID: 25945786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
    Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ
    Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperglycemia and Phosphatidylinositol 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin (PI3K/AKT/mTOR) Inhibitors in Phase I Trials: Incidence, Predictive Factors, and Management.
    Khan KH; Wong M; Rihawi K; Bodla S; Morganstein D; Banerji U; Molife LR
    Oncologist; 2016 Jul; 21(7):855-60. PubMed ID: 27151652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fisetin regulates obesity by targeting mTORC1 signaling.
    Jung CH; Kim H; Ahn J; Jeon TI; Lee DH; Ha TY
    J Nutr Biochem; 2013 Aug; 24(8):1547-54. PubMed ID: 23517912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.
    Xin P; Li C; Zheng Y; Peng Q; Xiao H; Huang Y; Zhu X
    Drug Des Devel Ther; 2017; 11():1115-1126. PubMed ID: 28435223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The cloning of human Smac gene and its pro-apoptotic effect on Burkitt's lymphoma cells].
    Lu C; Wu SH; Chen JQ; Zhao F; Chi X; Pan XQ; Fei L; Guo M; Huang SM; Guo XR; Chen RH
    Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):503-6. PubMed ID: 16083549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.